Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-051625
Filing Date
2012-09-17
Accepted
2012-09-17 09:46:47
Documents
1
Period of Report
2012-09-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v323862_4.html 4  
1 OWNERSHIP DOCUMENT v323862_4.xml 4 5383
  Complete submission text file 0001144204-12-051625.txt   7016
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 SEVENTH AVENUE, 48TH FLOOR NEW YORK NY 10019
Business Address
Power Sean A (Reporting) CIK: 0001538845 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 121094161